Cencora, Inc.

COR

US03073E1055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:04 2024-07-12 pm EDT			5-day change	1st Jan Change
222.6 ^USD	+0.26%		-0.04%	+8.38%

Jul. 09	Baird Adjusts Cencora's Price Target to $285 From $280, Keeps Outperform Rating	MT
Jul. 09	TD Cowen Adjusts Cencora's Price Target to $271 From $265, Keeps Buy Rating	MT

Amerisourcebergen Announces Updates Financial Outlook for the Fiscal Year 2021

January 06, 2021 at 07:10 am EST

AmerisourceBergen Corporation provided that previously communicated aspects of the Company's fiscal year 2021 financial guidance and assumptions remain the same.

Latest news about Cencora, Inc.

Baird Adjusts Cencora's Price Target to $285 From $280, Keeps Outperform Rating	Jul. 09	MT
TD Cowen Adjusts Cencora's Price Target to $271 From $265, Keeps Buy Rating	Jul. 09	MT
Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug	Jul. 08	MT
Top law firms in US opioid lawsuits to get hundreds of millions in fees	Jun. 07	RE
Cencora Insider Sold Shares Worth $419,506, According to a Recent SEC Filing	Jun. 03	MT
Cencora, Inc. Revises Earnings Guidance for the Fiscal Year 2024	May. 30	CI
Transcript : Cencora, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 09:20 AM	May. 30
Baird Adjusts Price Target on Cencora to $280 From $277	May. 29	MT
Cencora Notifies Individuals Affected by Data Breach	May. 24	MT
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	May. 23
The market is good to go until Nvidia’s next quarterly results	May. 23
Walgreens Boots Alliance Sells $400 Million of Cencora Shares	May. 23	MT
Walgreens further cuts stake in drug distributor Cencora	May. 22	RE
Walgreens reduces stake in Cencora	May. 22	RE
Cencora Insider Sold Shares Worth $2,380,082, According to a Recent SEC Filing	May. 22	MT
JPMorgan Adjusts Price Target on Cencora to $280 From $270	May. 17	MT
Jefferies Adjusts Price Target on Cencora to $230 From $235	May. 08	MT
Cencora, Inc. Announces Retirement of Gina K. Clark, Executive Vice President and Chief Communications & Administrative Officer	May. 03	CI
Wells Fargo Adjusts Cencora Price Target to $236 From $235	May. 03	MT
UBS Adjusts Price Target on Cencora to $275 From $277, Maintains Buy Rating	May. 02	MT
TD Cowen Adjusts Price Target on Cencora to $265 From $261	May. 02	MT
Evercore ISI Adjusts Cencora Price Target to $260 From $270	May. 02	MT
Tranche Update on Cencora, Inc.'s Equity Buyback Plan announced on May 2, 2023.	May. 01	CI
Cencora, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 01	CI
Transcript : Cencora, Inc., Q2 2024 Earnings Call, May 01, 2024	May. 01

Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-31 - Q3 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Cencora, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

222.6 USD

Average target price

256.7 USD

Spread / Average Target

+15.31%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
CENCORA, INC.	+8.38%	43.84B
ABBOTT LABORATORIES	-5.31%	181B
MEDTRONIC PLC	-5.38%	99.95B
BECTON, DICKINSON AND COMPANY	-6.04%	66.21B
HOYA CORPORATION	+16.45%	45.4B
DEXCOM, INC.	-8.08%	45.36B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.06%	29.03B
TERUMO CORPORATION	+17.98%	25.64B
WEST PHARMACEUTICAL SERVICES, INC.	-8.28%	23.53B
ZIMMER BIOMET HOLDINGS, INC.	-10.69%	22.36B

Other Medical Equipment, Supplies & Distribution

Cencora, Inc.

Equities

COR

US03073E1055

Medical Equipment, Supplies & Distribution

Amerisourcebergen Announces Updates Financial Outlook for the Fiscal Year 2021

Latest news about Cencora, Inc.

Chart Cencora, Inc.

Company Profile

Income Statement Evolution

Ratings for Cencora, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution